ESC 365 - Meet the Experts - Safety first: avoiding adverse events with new cardiovascular drugs

ESC Premium Access

Meet the Experts - Safety first: avoiding adverse events with new cardiovascular drugs

Event: ESC Congress 2018

Topic: Cardiovascular Pharmacotherapy

Session type: Expert Session

Date: 26 August 2018

Time: 11:00 - 12:30

Congress Session

6 presentations in this session

Safety first: avoiding adverse events with new cardiovascular drugs - Panel

Introduction - Safety first: avoiding adverse events with new cardiovascular drugs

Speaker: Doctor M. Alonso Garcia (London, GB)

Scenario 1 - Adverse events of new lipid lowering drugs.

Speaker: Doctor T. Hall (Oslo, NO)

Scenario 2 - Neprilysin inhibitors in heart failure: safety and adverse events

Speaker: Assistant Professor M. Kaluzna-Oleksy (Poznan, PL)

Scenario 3 - Long-term safety of new anti-diabetic drugs.

Speaker: Associate Professor A. Niessner (Vienna, AT)

Safety first: avoiding adverse events with new cardiovascular drugs - Take Home Message.

Speaker: Professor J. Tamargo (Madrid, ES)

5 speakers from this session

Doctor Maria Angeles Alonso Garcia

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

2 presentations

0 follower

Doctor Trygve Sundby Hall

Oslo University Hospital Ulleval, Oslo (Norway)

4 presentations

0 follower

Assistant Professor Marta Izabela Kaluzna-Oleksy

Poznan University of Medical Sciences, Poznan (Poland)

4 presentations

0 follower

Associate Professor Alexander Niessner

Medical University of Vienna, Vienna (Austria)

6 presentations

0 follower

Professor Juan Luis Tamargo

Complutense University of Madrid, Madrid (Spain)

8 presentations

2 followers

This platform is supported by